ES8707731A1 - Un procedimiento para la preparacion de derivados de oxindol - Google Patents

Un procedimiento para la preparacion de derivados de oxindol

Info

Publication number
ES8707731A1
ES8707731A1 ES554609A ES554609A ES8707731A1 ES 8707731 A1 ES8707731 A1 ES 8707731A1 ES 554609 A ES554609 A ES 554609A ES 554609 A ES554609 A ES 554609A ES 8707731 A1 ES8707731 A1 ES 8707731A1
Authority
ES
Spain
Prior art keywords
het
procedure
preparation
oxindol derivatives
oxindol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554609A
Other languages
English (en)
Spanish (es)
Other versions
ES554609A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/666,953 external-priority patent/US4644005A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8707731A1 publication Critical patent/ES8707731A1/es
Publication of ES554609A0 publication Critical patent/ES554609A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES554609A 1984-10-31 1986-04-30 Un procedimiento para la preparacion de derivados de oxindol Expired ES8707731A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/666,953 US4644005A (en) 1984-10-31 1984-10-31 Oxindole antiinflammatory agents
US06/762,998 US4686224A (en) 1984-10-31 1985-08-06 Oxindole antiinflammatory agents

Publications (2)

Publication Number Publication Date
ES8707731A1 true ES8707731A1 (es) 1987-08-16
ES554609A0 ES554609A0 (es) 1987-08-16

Family

ID=27099577

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554609A Expired ES8707731A1 (es) 1984-10-31 1986-04-30 Un procedimiento para la preparacion de derivados de oxindol

Country Status (16)

Country Link
US (1) US4686224A (2)
EP (1) EP0181136B1 (2)
KR (1) KR870001269B1 (2)
AU (1) AU555051B2 (2)
CA (1) CA1247099A (2)
DE (1) DE3585719D1 (2)
DK (1) DK163990C (2)
ES (1) ES8707731A1 (2)
FI (1) FI81340C (2)
GR (1) GR852629B (2)
HU (1) HU194168B (2)
IE (1) IE58207B1 (2)
IL (1) IL76854A (2)
PH (3) PH20985A (2)
PL (2) PL145239B1 (2)
PT (1) PT81393B (2)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5128352A (en) * 1989-01-10 1992-07-07 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
JPH0717589B2 (ja) * 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規１，３―ジカルボニル化合物およびその組成物
CH687764A5 (de) * 1992-07-02 1997-02-14 Lonza Ag Gampel Wallis Geschof Verfahren zur Herstellung von 7-Acylindolen.
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
US7855297B2 (en) 2000-09-14 2010-12-21 Mitsubishi Tanabe Pharma Corporation Amide derivatives and medicinal use thereof
WO2002070478A1 (en) 2001-03-06 2002-09-12 Astrazeneca Ab Indolone derivatives having vascular-damaging activity
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104130176A (zh) * 2014-06-13 2014-11-05 天津科技大学 一种1,5-二取代吲哚酮类衍生物及其应用
WO2025143096A1 (ja) * 2023-12-29 2025-07-03 キッセイ薬品工業株式会社 含窒素縮環化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
EP0276500B1 (en) * 1984-02-07 1991-05-15 Pfizer Inc. 2-oxindole intermediates
PT80116B (pt) * 1984-03-19 1987-10-20 Pfizer Processo para a producao de 2-oxindole-1-carboxamidas e de intermediarios para esse efeito
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Also Published As

Publication number Publication date
DE3585719D1 (de) 1992-04-30
IE852703L (en) 1986-04-30
DK163990C (da) 1992-09-21
PT81393B (pt) 1988-02-17
CA1247099A (en) 1988-12-20
FI81340C (fi) 1990-10-10
PL255990A1 (en) 1987-03-23
PH24091A (en) 1990-03-05
AU555051B2 (en) 1986-09-11
PL145239B1 (en) 1988-08-31
DK163990B (da) 1992-04-27
EP0181136A2 (en) 1986-05-14
KR860003260A (ko) 1986-05-21
FI81340B (fi) 1990-06-29
EP0181136B1 (en) 1992-03-25
EP0181136A3 (en) 1987-10-28
FI854258L (fi) 1986-05-01
IL76854A0 (en) 1986-02-28
PH23130A (en) 1989-05-05
PH20985A (en) 1987-06-18
US4686224A (en) 1987-08-11
DK497685A (da) 1986-05-01
FI854258A0 (fi) 1985-10-30
HU194168B (en) 1988-01-28
GR852629B (2) 1986-03-04
HUT39428A (en) 1986-09-29
PT81393A (en) 1985-11-01
IE58207B1 (en) 1993-07-28
ES554609A0 (es) 1987-08-16
PL262327A1 (en) 1987-11-02
AU4918985A (en) 1986-05-08
PL150842B1 (en) 1990-07-31
IL76854A (en) 1989-05-15
DK497685D0 (da) 1985-10-30
KR870001269B1 (ko) 1987-06-30

Similar Documents

Publication Publication Date Title
ES8707731A1 (es) Un procedimiento para la preparacion de derivados de oxindol
ES8303382A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
ES8206443A1 (es) Un procedimiento para preparar un derivado de amidina
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
PT97888A (pt) Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
ES8301966A1 (es) Procedimiento para preparar derivados de pirimidona
ES2036852T3 (es) Procedimiento para la obtencion de trifluormetilfenil-azolilmetiloxiranos y su empleo como agentes protectores de las plantas.
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
ES8704497A1 (es) Un procedimiento para la preparacion de oxindal-carboxamidas triciclicas.
ES8801285A1 (es) Procedimiento para la obtencion de derivados de la 13-beta-milbemicina
ES8104323A1 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES8106482A1 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES8305707A1 (es) Procedimiento para preparar derivados de quanadina.
ES8800164A1 (es) Un procedimiento para preparar derivados de imidazolidina
ES2090374T3 (es) Derivados de tiazolina, procesos para su preparacion y composiciones plaguicidas que los contienen.
ES8304120A1 (es) Un procedimiento para la preparacion de nuevos derivados de acilaminoquimazolina.
ES8706644A1 (es) Un procedimiento para preparar derivados de dihidropiridazina
DK508484D0 (da) N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem
ES500810A0 (es) Procedimiento de preparacion de aminoalcoxipirazoles
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
ES516362A0 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
ES8300722A1 (es) Procedimiento para la preparacion de carbamoiloxiamino-1,4- benzodiazepinas
PL211567A1 (pl) Sposob wytwarzania zwiazku optycznie czynnego
ES8104210A1 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido.
ATE86973T1 (de) Eicosattraynsaeureamide, ihre verwendung in der arzneimittelkunde und kosmetika, ihre herstellung und verfahren zur herstellung von eicosattraynsaeure.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401